+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific High-Flow Nasal Cannula Market to 2027- Regional Analysis and Forecasts by Component; Application; End User and Country

  • ID: 4987782
  • Report
  • January 2020
  • Region: Asia Pacific
  • 129 pages
  • The Insight Partners
UP TO OFF
until Sep 30th 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Flexicare Medical Limited
  • Hamilton Medical Inc,
  • Mek-Ics Co., Ltd.
  • Resmed
  • Salter Labs
  • Teleflex Incorporated
  • MORE
The APAC high-flow nasal cannula market is expected to reach US$ 2,536.52 Mn in 2027 from US$ 951.53 Mn in 2018. The market is projected to grow with a CAGR of 11.7% from 2019-2027.

The growth of the market is majorly contributed by growing elderly population and increasing chronic respiratory disease across APAC. However, after effects of high flow nasal cannula is likely to have a negative impact on the growth of the market in the coming years.

COPD cases in India has increased from 28.1 million (27.0-29.2) in 1990 to 55.3 million (53.1-57.6) in 2016. Also, an increase in prevalence was observed from 3.3% to 4.2%. The age-standardized COPD prevalence and DALY rates in 2016 were highest in the less developed low epidemiological transition level (ETL) state group. According to the University of Washington’s Global Burden of Disease study, 2018, after heart disease, Chronic Obstructive Pulmonary Disease (COPD) was the second - highest cause of death in India in 2017, killing approximately 1 million (958,000) Indians. Moreover, as per the IndiaSpend reported in January 2018, COPD led to 13% of all deaths in India, and 7.5 million were at risk of the disease in 2016. Thus, the demand for high flow nasal cannula market is expected to increase in the forecast period.

In 2018, the India high-flow nasal cannula market held the largest share of the APAC high-flow nasal cannula market. India has largest share and fastest growing because various research institutes focus on improving the standard of the treatment for COPD. For instance, Chest Research Foundation (CRF) in Pune, India, conducts research on airways diseases such as asthma and COPD in India, especially with the focus on regional variations and etiological factors and clinical evaluation of drugs for the treatment of these diseases.

The hospital segment expected to dominate the APAC high-flow nasal cannula market. Additionally, this segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027. Similarly, in 2018 the active humidifier segment held the major market share among the component segments.

By Component, the active humidifier segment held a largest market share of the high-flow nasal cannula market, in 2018. The active humidifier is expected to dominate its market share in 2027 because presence of many market players who are providing heated circuits and systems to deliver humidification. The active humidifier segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.

Chronic Obstructive Pulmonary Disease segment a largest market share of the high-flow nasal cannula market, by application in 2018. However, bronchiectasis segment expected to have largest market in 2027 because patients with bronchiectasis are growing consistently since 2001 and its prevalence is more in elder population.

Some of the major primary and secondary sources for drug delivery systems included in the report are the National Center for Biotechnology Information (NCBI), NCD Alliance, etc.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the high-flow nasal cannula market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the APAC high-flow nasal cannula market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Flexicare Medical Limited
  • Hamilton Medical Inc,
  • Mek-Ics Co., Ltd.
  • Resmed
  • Salter Labs
  • Teleflex Incorporated
  • MORE
1. Introduction
1.1 Scope of The Study
1.2 Research Report Guidance

2. Asia-Pacific High-Flow Nasal Cannula Market - Key Takeaways

3. Asia-Pacific High-Flow Nasal Cannula Market- Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Asia-Pacific High-Flow Nasal Cannula Market - By Component
3.2.2 Asia-Pacific High-Flow Nasal Cannula Market - By Application
3.2.3 Asia-Pacific High-Flow Nasal Cannula Market - By End User
3.2.4 Asia-Pacific High-Flow Nasal Cannula Market - By Asia Pacific Countries
3.3 Pest Analysis

4. Asia-Pacific High-Flow Nasal Cannula Market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Growing Elderly Population
4.1.2 Increasing Chronic Respiratory Disease Across APAC
4.2 Key Market Restraints
4.2.1 After Effects Of High Flow Nasal Cannula
4.3 Key Market Opportunity
4.3.1 Emerging Markets in Asia Pacific Region
4.4 Future Trend
4.4.1 Growing Usage of Home Based Oxygen Therapy
4.5 Impact Analysis

5. High-Flow Nasal Cannula Market - Asia-Pacific Analysis
5.1 Asia-Pacific High-Flow Nasal Cannula Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players

6. Asia-Pacific High-Flow Nasal Cannula Market Analysis - By Component
6.1 Overview
6.2 Component Market Revenue And Forecasts Analysis (US$ Mn)
6.3 Air Oxygen Blender
6.3.1 Overview
6.3.2 Asia-Pacific Air Oxygen Blender Market Revenue and Forecast to 2027 (US$ Mn)
6.4 Nasal Cannula
6.4.1 Overview
6.4.2 Asia-Pacific Nasal Cannula Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Heated Inspiratory Circuit
6.5.1 Overview
6.5.2 Asia-Pacific Heated Inspiratory Circuit Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Active Humidifier
6.6.1 Overview
6.6.2 Asia-Pacific Active Humidifier Market Revenue and Forecast to 2027 (US$ Mn)

7. Asia-Pacific High-Flow Nasal Cannula Market Analysis - By Application
7.1 Overview
7.2 Asia-Pacific High-Flow Nasal Cannula Market, By Application 2018 & 2027 (%)
7.3 Bronchiectasis
7.3.1 Overview
7.3.2 Asia-Pacific Bronchiectasis Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Acute Respiratory Failure
7.4.1 Overview
7.4.2 Asia-Pacific Acute Respiratory Failure Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Acute Heart Failure
7.5.1 Overview
7.5.2 Asia-Pacific Acute Heart Failure Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Chronic Obstructive Pulmonary Disease
7.6.1 Overview
7.6.2 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Revenue and Forecast to 2027 (US$ Mn)

8. Asia-Pacific High-Flow Nasal Cannula Market Analysis - By End User
8.1 Overview
8.2 Asia-Pacific High-Flow Nasal Cannula Market, By Applicaton 2018 & 2027 (%)
8.3 Ambulatory Surgical Centers
8.3.1 Overview
8.3.2 Asia-Pacific Ambulatory Surgical Centers Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Hospitals
8.4.1 Overview
8.4.2 Asia-Pacific Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Long-Term Care Centers
8.5.1 Overview
8.5.2 Asia-Pacific Long-Term Care Centers Market Revenue and Forecast to 2027 (US$ Mn)

9. Asia-Pacific High-Flow Nasal Cannula Market Revenue And Forecasts To 2027
9.1 Asia-Pacific High-Flow Nasal Cannula Market
9.1.1 Asia Pacific High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.2 Asia Pacific High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.3 Asia Pacific High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.4 Asia Pacific High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.5 Asia Pacific High-Flow Nasal Cannula Market Revenue and Forecast to 2027, By Country (%)
9.1.6 China
9.1.6.1 China High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 China High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.6.3 China High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.6.4 China High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.7 Japan
9.1.7.1 Japan High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Japan High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.7.3 Japan High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.7.4 Japan High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.8 India
9.1.8.1 India High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 India High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.8.3 India High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.8.4 India High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.9 South Korea
9.1.9.1 South Korea High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.2 South Korea High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.9.3 South Korea High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.9.4 South Korea High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.10 Australia
9.1.10.1 Australia High-Flow Nasal Cannula Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.2 Australia High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.1.10.3 Australia High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.10.4 Australia High-Flow Nasal Cannula Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10. High-Flow Nasal Cannula Market -Industry Landscape
10.1 Overview
10.1.1 Recent Developments by Players in the High-Flow Nasal Cannula Market

11. High-Flow Nasal Cannula Market-Key Company Profiles
11.1 Fisher & Paykel Healthcare Limited
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Resmed.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Teleflex Incorporated
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Information
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Hamilton Company
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Great Group Medical Co., Ltd.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Information
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Salter Labs (Sunmed, LLC)
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 TNI Medical AG.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Flexicare (Group) Limited
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Vapotherm
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Mek-Ics Co., Ltd.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Solution Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments

12. Appendix
12.1 About the Publisher
12.2 Glossary Of Terms
12.3 Methodology
12.4 Coverage
12.5 Secondary Research
Note: Product cover images may vary from those shown
3 of 3
  • Great Group Medical Co., Ltd.
  • Salter Labs
  • Fisher And Paykel Healthcare Limited
  • TNI Medical Ag
  • Mek-Ics Co., Ltd.
  • Flexicare Medical Limited
  • Vapotherm
  • Teleflex Incorporated
  • Resmed
  • Hamilton Medical Inc,
Note: Product cover images may vary from those shown
Adroll
adroll